Matrix metalloproteinases, tissue inhibitor of matrix metalloproteinase-1, and laminin-5 γ2 chain immunolocalization in gingival tissue of endotoxin-induced periodontitis in rats: Effects of low-dose doxycycline and alendronate

Journal of Periodontology

Volumn 78, Issue 1, 2007, Pages 127-134

  Buduneli, Eralp ^a   Vardar Şengül, Saynur ^a   Buduneli, Nurcan ^a   Atilla, Gül ^a   Wahlgren, Jaana ^b   Sorsa, Timo ^b  

^a EGE UNIVERSITY   (Turkey)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Alendronate; Bisphosphonates; Doxycycline; Laminin 5; MMPs; TIMP 1

Indexed keywords

ALENDRONIC ACID; COLLAGENASE 3; DOXYCYCLINE; KALININ; LIPOPOLYSACCHARIDE; MATRIX METALLOPROTEINASE 14; NEUTROPHIL COLLAGENASE; SODIUM CHLORIDE; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG POTENTIATION; IMMUNOHISTOCHEMISTRY; KRUSKAL WALLIS TEST; LOW DRUG DOSE; MALE; MONOTHERAPY; MORPHOLOGY; NONHUMAN; OSTEOLYSIS; PERIODONTITIS; PROTEIN EXPRESSION; RANK SUM TEST; RAT; STEREOMICROSCOPY;

ALENDRONATE; ALVEOLAR BONE LOSS; ANIMALS; ANTI-BACTERIAL AGENTS; BONE DENSITY CONSERVATION AGENTS; CELL ADHESION MOLECULES; DOXYCYCLINE; DRUG COMBINATIONS; ESCHERICHIA COLI; GINGIVA; IMMUNOENZYME TECHNIQUES; LIPOPOLYSACCHARIDES; MALE; MATRIX METALLOPROTEINASES; PERIODONTITIS; PROTEASE INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; STATISTICS, NONPARAMETRIC; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 33846685949     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2007.050451     Document Type: Article

References (50)

1. Birkedal-Hansen H, Moore WG, Bodden MK, et al. Matrix metalloproteinases: A review. Crit Rev Oral Biol Med 1993;4:197-250.
2. Sorsa T, Tjaderhane L, Salo T. Matrix metalloproteinases (MMPs) in oral diseases. Oral Dis 2004;10: 311-318.
3. Ingman T, Tervahartiala T, Ding Y, et al. Matrix metalloproteinases and their inhibitors in gingival crevicular fluid and saliva of periodontitis patients. J Clin Periodontol 1996;23:1127-1132.
4. Hanemaaijer R, Sorsa T, Konttinen YT, et al. Matrix metalloproteinase-8 is expressed in rheumatoid synovial fibroblasts and endothelial cells. Regulation by tumor necrosis factor-alpha and doxycycline. J Biol Chem 1997;272:31504-31509.
5. Wahlgren J, Maisi P, Sorsa T, et al. Expression and induction of collagenases (MMP-8 and -13) in plasma cells associated with bone-destructive lesions. J Pathol 2001;194:217-224.
6. Tervahartiala T, Pirila E, Ceponis A, et al. The in vivo expression of the collagenolytic matrix metalloproteinases (MMP-2, -8, -13, and -14) and matrilysin (MMP-7) in adult and localized juvenile periodontitis. J Dent Res 2000;79:1969-1977.
7. Kiili M, Cox SW, Chen HY, et al. Collagenase-2 (MMP-8) and collagenase-3 (MMP-13) in adult periodontitis: Molecular forms and levels in gingival crevicular fluid and immunolocalisation in gingival tissue. J Clin Periodontol 2002;29:224-232.
8. Fuller K, Chambers TJ. Localisation of mRNA for collagenase in osteocytic, bone surface and chondrocytic cells but not osteoclasts. J Cell Sci 1995;108: 2221-2230.
9. Knauper V, Will H, Lopez-Otin C, et al. Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme. J Biol Chem 1996;271:17124-17131.
10. Uitto VJ, Overall CM, McCulloch C. Proteolytic host cell enzymes in gingival crevice fluid. Periodontol 2000 2003;31:77-104.
11. Aiba T, Akeno N, Kawane T, Okamoto H, Horiuchi N. Matrix metalloproteinases-1 and -8 and TIMP-1 mRNA levels in normal and diseased human gingivae. Eur J Oral Sci 1996;104:562-569.
12. Howard EW, Bullen EC, Banda MJ. Preferential inhibition of 72- and 92-kDa gelatinases by tissue inhibitor of metalloproteinases-2. J Biol Chem 1991;266: 13070-13075.
13. Gurses N, Thorup AK, Reibel J, Carter WG, Holmstrup P. Expression of VLA-integrins and their related basement membrane ligands in gingiva from patients of various periodontitis categories. J Clin Periodontol 1999;26:217-224.
14. Pirila E, Maisi P, Salo T, Koivunen E, Sorsa T. In vivo localization of gelatinases (MMP-2 and -9) by in situ zymography with a selective gelatinase inhibitor. Biochem Biophys Res Commun 2001;287:766-774.
15. Atsuta I, Yamaza T, Yoshinari M, et al. Ultrastructural localization of laminin-5 (gamma2 chain) in the rat peri-implant oral mucosa around a titanium-dental implant by immuno-electron microscopy. Biomaterials 2005;26:6280-6287.
16. Koshikawa N, Giannelli G, Cirulli V, Miyazaki K, Quaranta V. Role of cell surface metalloprotease MT1-MMP in epithelial cell migration over laminin-5. J Cell Biol 2000;148:615-624.
17. Kornman KS. Host modulation as a therapeutic strategy in the treatment of periodontal disease. Clin Infect Dis 1999;28:520-526.
18. Golub LM, McNamara TF, Ryan ME, et al. Adjunctive treatment with subantimicrobial doses of doxycycline: Effects on gingival fluid collagenase activity and attachment loss in adult periodontitis. J Clin Periodontol 2001;28:146-156.
19. Emingil G, Atilla G, Sorsa T, Luoto H, Kirilmaz L, Baylas H. The effect of adjunctive low-dose doxycycline therapy on clinical parameters and gingival crevicular fluid matrix metalloproteinase-8 levels in chronic periodontitis. J Periodontol 2004;75:106-115.
20. Golub LM, Lee HM, Greenwald RA, et al. A matrix metalloproteinase inhibitor reduces bone-type collagen degradation fragments and specific collagenases in gingival crevicular fluid during adult periodontitis. Inflamm Res 1997;46:310-319.
21. Emingil G, Atilla G, Sorsa T, Savolainen P, Baylas H. Effectiveness of adjunctive low-dose doxycycline therapy on clinical parameters and gingival crevicular fluid laminin-5 gamma2 chain levels in chronic periodontitis. J Periodontol 2004;75:1387-1396.
22. Kaynak D, Meffert R, Günhan M, Günhan Ö, Özkaya Ö. A histopathological investigation on the effects of the biphosphonate alendronate on resorptive phase following mucoperiosteal flap surgery in the mandible of rats. J Periodontol 2000;71:790-796.
23. Binderman I, Adut M, Yaffe A. Effectiveness of local delivery of alendronate in reducing alveolar bone loss following periodontal surgery in rats. J Periodontol 2000;71:1236-1240.
24. Alencar VB, Bezerra MM, Lima V, et al. Disodium clodronate prevents bone resorption in experimental periodontitis in rats. J Periodontol 2002;73:251-256.
25. Mitsuta T, Horiuchi H, Shinoda H. Effects of topical administration of clodronate on alveolar bone resorption in rats with experimental periodontitis. J Periodontol 2002;73:479-486.
26. Sato M, Grasser W. Effects of biphosphonates on isolated rat osteoclasts as examined by reflected light microscopy. J Bone Miner Res 1990;5:31-40.
27. Teronen O, Heikkila P, Konttinen YT, et al. MMP inhibition and downregulation by bisphosphonates. Ann N Y Acad Sci 1999;878:453-465.
28. Rocha M, Nava LE, Vazquez de la Torre C, Sanchez-Marin F, Garay-Sevilla ME, Malacara JM. Clinical and radiological improvement of periodontal disease in patients with type 2 diabetes mellitus treated with alendronate: A randomized, placebo-controlled trial. J Periodontol 2001;72:204-209.
29. Ramamurthy NS, Golub LM, Gwinnett AJ, Salo T, Ding Y, Sorsa T. In vivo and in vitro inhibition of metalloproteinases including MMP-13 by several chemically modified tetracyclines (CMTs). In: Davidovitch D, Mah J, eds. Biologic Mechanisms of Tooth Eruption, Resorption and Replacement by Implants. Boston: Harvard Society for the Advancement of Orthodontics; 1998:271-277.
30. Yaffe A, Fine N, Alt I, Binderman I. The effect of biphosphonate on alveolar bone resorption following mucoperiosteal flap surgery in the mandible of rats. J Periodontol 1995;66:999-1003.
31. Hanemaaijer R, Sorsa T, Konttinen YT, et al. Matrix metalloproteinase-8 is expressed in rheumatoid synovial fibroblasts and endothelial cells. J Biol Chem 1997;272:31504-31509.
32. Sorsa T, Mäntylä P, Rönkä H, et al. Scientific basis of matrix metalloproteinase-8 specific chair-side test for monitoring periodontal and peri-implant health and disease. Ann N Y Acad Sci 1999;878:130-140.
33. Lindy O, Konttinen YT, Sorsa T, et al. Matrix metalloproteinase-13 (collagenase-3) in human rheumatoid synovium. Arthritis Rheum 1997;40:1391-1399.
34. Pyke C, Salo S, Ralfkiaer E, Romer J, Dano K, Tryggvason K. Laminin-5 is a marker of invading cancer cells in some human carcinomas and is coexpressed with the receptor for urokinase plasminogen activator in budding cancer cells in colon adenocarcinomas. Cancer Res 1995;55:4132-4139.
35. Prikk K, Maisi P, Pirila E, et al. In vivo collagenase-2 (MMP-8) expression by human bronchial epithelial cells and monocytes/macrophages in bronchiectasis. J Pathol 2001;194:232-238.
36. Ingman T, Sorsa T, Michaelis J, Konttinen YT. Immuno-histochemical study of neutrophil- and fibroblast-type collagenases and stromelysin-1 in adult periodontitis. Scand J Dent Res 1994;102:342-349.
37. Ejeil AL, Igondjo-Tchen S, Ghomrasseni S, Pellat B, Godeau G, Gogly B. Expression of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in healthy and diseased human gingiva. J Periodontol 2003;74:188-195.
38. Dahan M, Nawrocki B, Elkaim R, et al. Expression of matrix metalloproteinases in healthy and diseased human gingiva. J Clin Periodontol 2001;28:128-136.
39. Llavaneras A, Ramamurthy NS, Heikkila P, et al. A combination of a chemically modified doxycycline and a biphosphonate synergistically inhibits endotoxin-induced periodontal breakdown in rats. J Periodontol 2001;72:1069-1077.
40. Achong R, Nishimura I, Ramachandran H, Howell TH, Fiorellini JP, Karimbux NY. Membrane type (MT) 1-matrix metalloproteinase (MMP) and MMP-2 expression in ligature-induced periodontitis in the rat. J Periodontol 2003;74:494-500.
41. Soell M, Elkaim R, Tenenbaum H. Cathepsin C, matrix metalloproteinases, and their tissue inhibitors in gingiva and gingival crevicular fluid from periodontitis-affected patients. J Dent Res 2002;81:174-178.
42. Choi DH, Moon IS, Choi BK, et al. Effects of sub-antimicrobial dose doxycycline therapy on crevicular fluid MMP-8, and gingival tissue MMP-9, TIMP-1 and IL-6 levels in chronic periodontitis. J Periodontal Res 2004;39:20-26.
43. Karimbux NY, Ramamurthy NS, Golub LM, Hishimura I. The expression of collagen I and XII mRNAs in Porphyromonas gingivalis-induced periodontitis in rats: The effect of doxycycline and chemically modified tetracycline. J Periodontol 1998;69:34-40.
44. Ramamurthy NS, Rifkin BR, Greenwald RA, et al. Inhibition of matrix metalloproteinase-mediated periodontal bone loss in rats: A comparison of six chemically modified tetracyclines. J Periodontol 2002;73: 726-734.
45. Bezerra MM, Brito GAC, Ribeiro RA, Rocha FAC. Low-dose doxycycline prevents inflammatory bone resorption in rats. Braz J Med Biol Res 2002;35: 613-616.
46. Buduneli E, Vardar S, Buduneli N, et al. Effects of combined systemic administration of low-dose doxycycline and alendronate on endotoxin-induced periodontitis in rats. J Periodontol 2004;75:1516-1523.
47. Adami S, Zamberlan M, Mian M, et al. Duration of the effect of intravenous alendronate in postmenopausal women and in patients with primary hyperparathyroidism and Paget's disease of bone. Bone Miner 1994;25:75-82.
48. Shoji K, Horiuchi H, Shinoda H. Inhibitory effects of a biphosphonate (risedronate) on experimental periodontitis in rats. J Periodontal Res 1995;30:277-284.
49. Reddy MS, Weatherford TW, Smith CA, West BD, Jeffcoat MK, Jacks TM. Alendronate treatment of naturally occurring periodontitis in beagle dogs. J Periodontol 1995;66:211-217.
50. Heikkila P, Teronen O, Moilanen M, et al. Bisphosphonates inhibit stromelysin-1 (MMP-3), matrix metalloelastase (MMP-12), collagenase-3 (MMP-13) and enamelysin (MMP-20), but not urokinase-type plasminogen activator, and diminish invasion and migration of human malignant and endothelial cell lines. Anticancer Drugs 2002;13:245-254.